贝伐珠单抗
參見

↑  . NLM.nih.gov. 2014-02-28. （原始内容存档于2014-03-25）.
1 2 3 4  . DailyMed. 2022-11-23  [2023-02-11]. （原始内容存档于2023-02-11）.
1 2  . DailyMed. 2019-06-25  [2020-03-18]. （原始内容存档于2020-07-27）.
1 2  . DailyMed. 2020-01-27  [2020 -03-18]. （原始内容存档于2020-07-27）.  请检查|access-date=中的日期值 (帮助)
1 2 3 4  . DailyMed. 2022-04-13  [2022-04-20]. （原始内容存档于2022-06-10）.
1 2 3  . European Medicines Agency (EMA). 2021-02-24  [2021-08-27]. （原始内容存档于2021-08-28）.
1 2 3 4  . European Medicines Agency (EMA). 2021-01-25  [2021-05-19]. （原始内容存档于2021-10-08）.  Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
1 2 3  . European Medicines Agency (EMA). 2020-05-26  [2020-09-09]. （原始内容存档于2020-12-29）.
1 2  . Health Canada. 2014-10-23  [2022-05-29]. （原始内容存档于2022-05-29）.
1 2 3 4 5 6  .   [2021-12-29]. （原始内容存档于2021-12-30）.
1 2 3 4 5 6 7  . European Medicines Agency (EMA). 2020-07-20  [2020-10-12]. （原始内容存档于2020-10-13）.  Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
1 2 3  . European Medicines Agency (EMA). 2018-09-17  [2020-04-02]. （原始内容存档于2019-12-30）.
1 2 3  . European Medicines Agency (EMA). 2020-11-09  [2021-05-19]. （原始内容存档于2021-11-05）.
1 2  . Therapeutic Goods Administration (TGA). 2024-02-06  [2024-03-07]. （原始内容存档于2024-02-08）.
1 2 3  . European Medicines Agency. 2021-01-28  [2023-03-03]. （原始内容存档于2021-10-08）.
1 2 3  . European Medicines Agency (EMA). 2022-06-20  [2023-03-03]. （原始内容存档于2023-01-28）.
1 2 3  . Therapeutic Goods Administration (TGA). 2023-09-18  [2024-03-07]. （原始内容存档于2024-01-02）.
1 2 3  . European Medicines Agency (EMA). 2018-12-11  [2 April 2020]. （原始内容存档于2019-12-30）.
1 2 3  . Therapeutic Goods Administration (TGA). 2021-09-15  [2021-09-17]. （原始内容存档于2021-09-16）.
↑  . Drugs.com. 2019-07-30  [2020-03-18]. （原始内容存档于2020-03-18）.
↑  . Therapeutic Goods Administration (TGA). 2022-02-02  [2022-06-12]. （原始内容存档于2022-05-31）.
↑  .   [2024-04-10]. （原始内容存档于2024-03-31）.
↑  . Health Canada. 2023-05-02  [2023-06-18]. （原始内容存档于2024-03-10）.
↑  . Health Canada. 2023-01-03  [2023-06-18]. （原始内容存档于10 March 2024）.
1 2  . European Medicines Agency (EMA). 2020-03-11  [2020-03-18]. （原始内容存档于2020-03-18）.
1 2 3  . DailyMed. 2019 -06-28  [2020-03-18]. （原始内容存档于2020-07-27）.  请检查|date=中的日期值 (帮助)
1 2 3 4 5 6 7 8 9  . The American Society of Health-System Pharmacists.   [2016-12-08]. （原始内容存档于2016-12-20）.
↑  . National Cancer Institute. 2006-10-05  [2023 -12-22]. （原始内容存档于2020-04-10）.  请检查|access-date=中的日期值 (帮助)
↑  . U.S. Food and Drug Administration (FDA). 2005-03-08  [2021-12-29]. （原始内容存档于2021-04-08）.
1 2  World Health Organization. . Geneva: World Health Organization. 2019. hdl:10665/325771 . WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
1 2  World Health Organization. . Geneva: World Health Organization. 2021. hdl:10665/345533 . WHO/MHP/HPS/EML/2021.02.
↑  World Health Organization. . Geneva: World Health Organization. 2023. hdl:10665/371090 . WHO/MHP/HPS/EML/2023.02.
1 2  Cohen MH, Gootenberg J, Keegan P, Pazdur R. . The Oncologist. March 2007, 12 (3): 356–61. PMID 17405901. S2CID 21241228. doi:10.1634/theoncologist.12-3-356 .
1 2   (PDF). European Medicines Agency. 2005. （原始内容 (PDF)存档于2015-09-24）.
↑  Van Cutsem E, Lambrechts D, Prenen H, Jain RK, Carmeliet P. . Journal of Clinical Oncology. January 2011, 29 (1): 1–4. PMID 21115866. doi:10.1200/JCO.2010.32.2701 .
1 2  Fogli S, Del Re M, Rofi E, Posarelli C, Figus M, Danesi R. . Eye. June 2018, 32 (6): 1010–1020. PMC 5997665 . PMID 29398697. doi:10.1038/s41433-018-0021-7.
↑  Arevalo JF, Fromow-Guerra J, Sanchez JG, Maia M, Berrocal MH, Wu L, Saravia MJ, Costa RA. . Retina. 2008, 28 (10): 1387–1394. PMID 18827735. S2CID 8694305. doi:10.1097/IAE.0b013e3181884ff4.
↑  Azad R, Chandra P. . Indian Journal of Ophthalmology. 2007, 55 (4): 319; author reply 320. PMID 17595491. doi:10.4103/0301-4738.33057 .
1 2  . U.S. Food and Drug Administration (FDA). 2018-06-13  [4 August 2018]. （原始内容存档于2020-03-18）.   本文含有此來源中屬於公有领域的内容。
↑  . U.S. Food and Drug Administration (FDA) (新闻稿). 2020-05-08  [2020-10-12]. （原始内容存档于2020-10-26）.   本文含有此來源中屬於公有领域的内容。
↑  Rosenfeld PJ, Reichel E. . Retina Today. May–June 2009: 26–29  [21 September 2021]. （原始内容存档于2021-09-21）.
↑  Sun XD, Xu WQ, Rosenfeld PJ. . [Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology. March 2008, 44 (3): 281–4. PMID 18785551 （Chinese）.  引文格式1维护：未识别语文类型 (link)
↑  ElSheikh RH, Chauhan MZ, Sallam AB. . Biomolecules. November 2022, 12 (11): 1629. PMC 9688017 . PMID 36358978. doi:10.3390/biom12111629 .
↑  Semenza GL. . The New England Journal of Medicine. May 2008, 358 (19): 2066–7. PMID 18463385. doi:10.1056/NEJMcibr0800272.
↑  Sliesoraitis S, Tawfik B. . The Journal of the American Osteopathic Association. July 2011, 111 (7): 437–41. PMID 21803880.
↑   (PDF). Genentech, Inc.   [e 2016-06-02]. （原始内容存档 (PDF)于2016-04-29）.  请检查|access-date=中的日期值 (帮助)
↑  Velcheti V, Viswanathan A, Govindan R. . Journal of Thoracic Oncology. June 2006, 1 (5): 501. PMID 17409907. doi:10.1097/01243894-200606000-00023.
↑  Vaughn C, Zhang L, Schiff D. . Current Oncology Reports. January 2008, 10 (1): 86–91. PMID 18366965. S2CID 40332552. doi:10.1007/s11912-008-0013-z.
↑  Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, Weisstuch J, Richardson C, Kopp JB, Kabir MG, Backx PH, Gerber HP, Ferrara N, Barisoni L, Alpers CE, Quaggin SE. . The New England Journal of Medicine. March 2008, 358 (11): 1129–36. PMC 3030578 . PMID 18337603. doi:10.1056/NEJMoa0707330.
↑  . CBC News. 2013-05-02  [2013-05-02]. （原始内容存档于2013-05-02）.
↑  Godfrey SE. . American Journal of Clinical Pathology. May 1989, 91 (5): 629–30. PMC 2718965 . PMID 2718965. doi:10.1215/15228517-2008-118.
1 2   (PDF). Gene.com. 2011. （原始内容存档 (PDF)于14 July 2011）.
↑  Los M, Roodhart JM, Voest EE. . The Oncologist. April 2007, 12 (4): 443–50. PMID 17470687. doi:10.1634/theoncologist.12-4-443 .
↑  Karpinska A, Magiera G, Kwapiszewska K, Hołyst R. . Journal of Physical Chemistry Letters. 2023, 14 (5): 1272–1278. PMC 9923738 . PMID 36719904. doi:10.1021/acs.jpclett.2c03590.
↑  Heiduschka P, Fietz H, Hofmeister S, Schultheiss S, Mack AF, Peters S, Ziemssen F, Niggemann B, Julien S, Bartz-Schmidt KU, Schraermeyer U. . Investigative Ophthalmology & Visual Science. June 2007, 48 (6): 2814–23. PMID 17525217. doi:10.1167/iovs.06-1171.
↑  Pollack A. . The New York Times. 2004-02-27. （原始内容存档于2016-10-24）.
↑  Palmer AM, Stephenson FA, Williams RJ. . Drug News & Perspectives. April 2007, 20 (3): 191–6. PMID 17520096.
↑  Ferrara N. . Disease Models & Mechanisms. 2009, 2 (7–8): 324–5. PMID 19553691. S2CID 22035397. doi:10.1242/dmm.002972.
1 2  Ribatti D. . Endothelium. 2008, 15 (1): 1–8. PMID 18568940. doi:10.1080/10623320802092377.
↑  Ferrara N. . The International Journal of Developmental Biology. 2011, 55 (4–5): 383–8. PMID 21858763. doi:10.1387/ijdb.103216dr .
1 2  . The New York Times. 22 February 2008. （原始内容存档于2017-02-02）.
↑  Pollack A. . The New York Times. 2011-11-18. （原始内容存档于2011-11-21）.
↑  . Australian Broadcasting Corporation. 2010-07-22. （原始内容存档于2010-07-23）.
↑  . The Guardian. 2015-01-10  [11 January 2015]. （原始内容存档于2015-01-15）.
↑  . www.england.nhs.uk.   [2023-03-09]. （原始内容存档于2023-03-09）.
1 2 3  . The British Medical Journal. 2015-04-01  [2015-04-02]. （原始内容存档于2015-04-04）.
1 2  . European Medicines Agency. 2024-03-21  [2024-03-23]. （原始内容存档于2024-04-01）.  Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
↑  Jasek W (编).  2007/2008. Vienna: Österreichischer Apothekerverlag. 2007. ISBN 978-3-85200-181-4 （德语）. [页码请求]
↑  . Reuters. 2012-02-15. （原始内容存档于2015-09-24）.
↑  Berkrot B. . Reuters. 2012-02-27  [2012-02-28]. （原始内容存档于2012-03-03）.
↑  Staton T. . FiercePharma. 2012-02-28  [2012-02-28]. （原始内容存档于2012-03-01）.
↑  Brennan Z. . BioPharma-Reporter. 2014-07-23  [2020-03-18]. （原始内容存档于2016-01-10）.
↑  . U.S. Food and Drug Administration (FDA) (新闻稿). 2017-09-14  [2020-10-12]. （原始内容存档于2021-11-05）.   本文含有此來源中屬於公有领域的内容。
↑  . U.S. Food and Drug Administration (FDA). 2017-09-14  [2020-10-12]. （原始内容存档于2020-09-21）.
↑  Gever J. . MedPage Today. 2017-09-14  [2020-03-18]. （原始内容存档于2017-09-16）.
↑  . U.S. Food and Drug Administration (FDA). 2019-08-14  [2021-12-29]. （原始内容存档于2019-12-18）.
↑  . Health Canada. 2014-10-23  [2022-05-29]. （原始内容存档于2022-05-31）.
↑  . Health Canada. 2014-10-23  [2022-05-29]. （原始内容存档于2022-05-30）.
↑  . Therapeutic Goods Administration (TGA). 2021 -11-16  [2021-12-29]. （原始内容存档于2021-12-30）.  请检查|date=中的日期值 (帮助)
↑  . Health Canada. 2014-10-23  [2022-05-29]. （原始内容存档于2022-05-29）.
↑  . Health Canada. 2014-10-23  [2022-05-29]. （原始内容存档于2022-05-29）.
↑  . Union Register of medicinal products.   [2023-03-03]. （原始内容存档于2023-03-04）.
↑  Enzene Biosciences Launches Bevacizumab 的存檔，存档日期2024-03-10. 2023-06-29
↑   (PDF). Bio-Thera Solutions, Ltd. U.S. Food and Drug Administration. 2020  [2023 -12-10]. （原始内容存档 (PDF)于2023-12-10）.  请检查|access-date=中的日期值 (帮助)
↑  . U.S. Food and Drug Administration. 2023-12-08  [2023-12-10]. （原始内容存档于2021-08-28）.
↑  Reed K. . Reuters. 2009-04-22  [2009-04-22]. （原始内容存档于2009-08-12）.
↑  Rossi L, Verrico M, Zaccarelli E, Papa A, Colonna M, Strudel M, Vici P, Bianco V, Tomao F. . Oncotarget. February 2017, 8 (7): 12389–12405. PMC 5355353 . PMID 27852039. doi:10.18632/oncotarget.13310.
↑  Diaz RJ, Ali S, Qadir MG, De La Fuente MI, Ivan ME, Komotar RJ. . Journal of Neuro-Oncology. July 2017, 133 (3): 455–467. PMID 28527008. S2CID 4964000. doi:10.1007/s11060-017-2477-x.
↑  Kim MM, Umemura Y, Leung D. . Cancer Journal (Sudbury, Mass.). 2018, 24 (4): 180–186. PMID 30119081. S2CID 52033623. doi:10.1097/PPO.0000000000000326.
↑  Rocha-Lima CM. . Anti-Cancer Drugs. June 2008, 19 (5): 435–46. PMID 18418211. S2CID 25507290. doi:10.1097/CAD.0b013e3282fc9d11.
↑  Riess H. . . Recent Results in Cancer Research 177. 2008: 123–9. ISBN 978-3-540-71266-4. PMID 18084954. doi:10.1007/978-3-540-71279-4_14.
↑  Navid F, Santana VM, Neel M, McCarville MB, Shulkin BL, Wu J, Billups CA, Mao S, Daryani VM, Stewart CF, Kunkel M, Smith W, Ward D, Pappo AS, Bahrami A, Loeb DM, Reikes Willert J, Rao BN, Daw NC. . International Journal of Cancer. October 2017, 141 (7): 1469–1477. PMC 5812455 . PMID 28631382. doi:10.1002/ijc.30841.
↑  Bogani G, Ditto A, Martinelli F, Signorelli M, Chiappa V, Fonatella C, Sanfilippo R, Leone Roberti Maggiore U, Ferrero S, Lorusso D, Raspagliesi F. . Critical Reviews in Oncology/Hematology. June 2018, 126: 45–51. PMID 29759566. S2CID 46890425. doi:10.1016/j.critrevonc.2018.03.019.
↑  Plotkin SR, Merker VL, Halpin C, Jennings D, McKenna MJ, Harris GJ, Barker FG.  (PDF). Otology & Neurotology. August 2012, 33 (6): 1046–52  [2019-08-02]. PMID 22805104. S2CID 205755932. doi:10.1097/MAO.0b013e31825e73f5. （原始内容存档 (PDF)于2024-03-10）.